{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:59:00Z","timestamp":1784689140937,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-022-01287-w","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T09:03:11Z","timestamp":1656320591000},"page":"161-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6826-9231","authenticated-orcid":false,"given":"Venkatesh","family":"Ravi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhushan","family":"Poudyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviral","family":"Vij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Trohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolga","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Santangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Winterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parikshit S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry D.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"issue":"14","key":"1287_CR1","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91\u2013220. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.054.","journal-title":"J Am Coll Cardiol."},{"issue":"21","key":"1287_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, American College of Cardiology\/American Heart Association task force on practice guidelines (writing committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices), American Association for Thoracic Surgery; Society of Thoracic Surgeons, et al. ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (writing committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1-62. https:\/\/doi.org\/10.1016\/j.jacc.2008.02.032.","journal-title":"J Am Coll Cardiol."},{"issue":"21","key":"1287_CR3","doi-asserted-by":"publisher","first-page":"08395","DOI":"10.1016\/j.jacc.2021.12.012","volume":"S0735\u20131097","author":"Writing Committee Members","year":"2022","unstructured":"Members Writing Committee, Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;S0735\u20131097(21):08395\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012.","journal-title":"J Am Coll Cardiol."},{"issue":"22","key":"1287_CR4","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","volume":"120","author":"DL Packer","year":"2009","unstructured":"Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120(22):2170\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.853689.","journal-title":"Circulation."},{"issue":"26","key":"1287_CR5","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","volume":"357","author":"VY Reddy","year":"2007","unstructured":"Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657\u201365. https:\/\/doi.org\/10.1056\/NEJMoa065457.","journal-title":"N Engl J Med."},{"issue":"13","key":"1287_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","volume":"141","author":"S Willems","year":"2020","unstructured":"Willems S, Tilz RR, Steven D, BERLIN VT Investigators, et al. Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial. Circulation. 2020;141(13):1057\u201367. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043400.","journal-title":"Circulation."},{"issue":"9708","key":"1287_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","volume":"375","author":"KH Kuck","year":"2010","unstructured":"Kuck KH, Schaumann A, Eckardt L, VTACH study group, et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375(9708):31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(09)61755-4.","journal-title":"Lancet."},{"issue":"3","key":"1287_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10840-020-00870-3","volume":"59","author":"G de Lima Silva","year":"2020","unstructured":"de Lima Silva G, Nunes-Ferreira A, Cortez-Dias N, de Sousa J, Pinto JF, Caldeira D. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol. 2020;59(3):603\u201316. https:\/\/doi.org\/10.1007\/s10840-020-00870-3.","journal-title":"J Interv Card Electrophysiol."},{"key":"1287_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059598","author":"P Della Bella","year":"2022","unstructured":"Della Bella P, Baratto F, Vergara P, et al. Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation. 2022. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059598.","journal-title":"Circulation."},{"issue":"15","key":"1287_CR10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","volume":"79","author":"\u00c1 Arenal","year":"2022","unstructured":"Arenal \u00c1, \u00c1vila P, Jim\u00e9nez-Candil J, et al. Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol. 2022;79(15):1441\u201353. https:\/\/doi.org\/10.1016\/j.jacc.2022.01.050.","journal-title":"J Am Coll Cardiol."},{"key":"1287_CR11","doi-asserted-by":"publisher","unstructured":"Tung R, Xue Y, Chen M, Jiang C, et al; PAUSE-SCD Investigators. First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial. Circulation. 2022. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060039.","DOI":"10.1161\/CIRCULATIONAHA.122.060039"},{"key":"1287_CR12","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, PRISMA Group. Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:2535.","journal-title":"BMJ."},{"key":"1287_CR13","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org\/handbook."},{"key":"1287_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges L, Higgins J, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97\u2013111.","journal-title":"Res Synth Methods."},{"key":"1287_CR15","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman A, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency. J Clin Epidemiol. 2011;64:1294\u2013302.","journal-title":"J Clin Epidemiol."},{"key":"1287_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1536867X0400400204","volume":"4","author":"J Sterne","year":"2004","unstructured":"Sterne J, Harbord R. Funnel plots in meta-analysis. The Stata Journal: Promoting communications on statistics and Stata. 2004;4:127\u201341.","journal-title":"The Stata Journal: Promoting communications on statistics and Stata."},{"issue":"2","key":"1287_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jce.12567","volume":"26","author":"SM Al-Khatib","year":"2015","unstructured":"Al-Khatib SM, Daubert JP, Anstrom KJ, et al. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015;26(2):151\u20137. https:\/\/doi.org\/10.1111\/jce.12567.","journal-title":"J Cardiovasc Electrophysiol."},{"issue":"2","key":"1287_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","volume":"375","author":"JL Sapp","year":"2016","unstructured":"Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1513614.","journal-title":"N Engl J Med."},{"issue":"3","key":"1287_CR19","doi-asserted-by":"publisher","first-page":"e004422.","DOI":"10.1161\/CIRCEP.116.004422","volume":"10","author":"KH Kuck","year":"2017","unstructured":"Kuck KH, Tilz RR, Deneke T, SMS Investigators, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (Substrate Modification Study). Circ Arrhythm Electrophysiol. 2017;10(3):e004422. https:\/\/doi.org\/10.1161\/CIRCEP.116.004422.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"4","key":"1287_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.hrthm.2013.12.014","volume":"11","author":"TJ Bunch","year":"2014","unstructured":"Bunch TJ, Weiss JP, Crandall BG, et al. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm. 2014;11(4):533\u201340. https:\/\/doi.org\/10.1016\/j.hrthm.2013.12.014.","journal-title":"Heart Rhythm."},{"key":"1287_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.amjcard.2020.09.010","volume":"136","author":"J Jim\u00e9nez Candil","year":"2020","unstructured":"Jim\u00e9nez Candil J, Castro JC, Hern\u00e1ndez J, et al. Timing of ablation and prognosis of patients with electrical storm and scar-related left ventricular dysfunction. Am J Cardiol. 2020;136:87\u201393. https:\/\/doi.org\/10.1016\/j.amjcard.2020.09.010.","journal-title":"Am J Cardiol."},{"issue":"1","key":"1287_CR22","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/j.hrthm.2019.04.024","volume":"17","author":"BK Martinez","year":"2020","unstructured":"Martinez BK, Baker WL, Konopka A, et al. Systematic review and meta-analysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm. 2020;17(1):e206\u201319. https:\/\/doi.org\/10.1016\/j.hrthm.2019.04.024.","journal-title":"Heart Rhythm."},{"issue":"2","key":"1287_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.295.2.165","volume":"295","author":"SJ Connolly","year":"2006","unstructured":"Connolly SJ, Dorian P, Roberts RS, Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA. 2006;295(2):165\u201371. https:\/\/doi.org\/10.1001\/jama.295.2.165.","journal-title":"JAMA."},{"issue":"2","key":"1287_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1161\/01.CIR.0000134957.51747.6E","volume":"110","author":"F Bokhari","year":"2004","unstructured":"Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2004;110(2):112\u20136. https:\/\/doi.org\/10.1161\/01.CIR.0000134957.51747.6E.","journal-title":"Circulation."},{"issue":"1","key":"1287_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40119-013-0012-5","volume":"2","author":"ES Williams","year":"2013","unstructured":"Williams ES, Viswanathan MN. Current and emerging antiarrhythmic drug therapy for ventricular tachycardia. Cardiol Ther. 2013;2(1):27\u201346. https:\/\/doi.org\/10.1007\/s40119-013-0012-5.","journal-title":"Cardiol Ther."},{"issue":"1","key":"1287_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/europace\/eux109","volume":"20","author":"DF Brice\u00f1o","year":"2018","unstructured":"Brice\u00f1o DF, Romero J, Villablanca PA, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. Europace. 2018;20(1):104\u201315. https:\/\/doi.org\/10.1093\/europace\/eux109.","journal-title":"Europace."},{"issue":"7","key":"1287_CR27","doi-asserted-by":"publisher","first-page":"e003901","DOI":"10.1161\/CIRCEP.116.003901","volume":"9","author":"S Yamashita","year":"2016","unstructured":"Yamashita S, Cochet H, Sacher F, et al. Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up. Circ Arrhythm Electrophysiol. 2016;9(7):e003901. https:\/\/doi.org\/10.1161\/CIRCEP.116.003901.","journal-title":"Circ Arrhythm Electrophysiol."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-022-01287-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-022-01287-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T08:01:08Z","timestamp":1676620868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-022-01287-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1007\/s10840-022-01287-w","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"12 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Timothy Larsen: speaking fees\/honoraria (Biosense Webster, Medtronic), consultant (Abbott). Dr. Richard G. Trohman: advisor (Boston Scientific\/Guidant), research grant support (Boston Scientific\/Guidant, Medtronic Inc., Abbott), consultant (Abbott), speaking fees\/honoraria (Boston Scientific\/Guidant CRM, Medtronic Inc., Abbott). Dr. Roderick Tung: speaking fees and advisory board (Abbott, Biotronik, Boston Scientific, Medtronic), research grant support (Abbott). Dr. Pasquale Santangeli: consultant (Biosense Webster, Abbott, Baylis Medical, InHeart, Farapulse), research grant support (Johnson and Johnson). Dr. Jeffrey Winterfield: consulting fees\/honoraria (Abbott, Biosense Webster, Thermedical). Dr. Parikshit S Sharma: speaking fees (Medtronic), consultant (Abbott, Boston Scientific, Biotronik). Dr. Henry D. Huang: Consultant (Cardiofocus), research grant support (Medtronic). The remaining authors declare that there are no relevant conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}